FDA clears Lilly's Olumiant for teens with severe alopecia areata

September 25, 2026 5:12 PM

Eli Lilly and Company (NYSE: LLY) said the U.S. Food and Drug Administration approved Olumiant (baricitinib) as a once-daily oral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found